SCHEMBL30407808

SCHEMBL30407808

COc1c(I)ccc(-c2ccc(OCc3ccccc3)nc2OCc2ccccc2)c1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MCL1 Q07820 1/20 0.40
▸ BAK1 Q16611 1/20 0.40
▸ GRM5 P41594 1/20 0.38
▸ ALDH1A1 P00352 3/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ PKM P14618 1/20 0.35
▸ CNR1 P21554 1/20 0.35
▸ PIN1 Q13526 1/20 0.34
▸ HTR1A P08908 1/20 0.34
▸ ADRA1D P25100 1/20 0.34
▸ ADRA1A P35348 1/20 0.34
▸ ADRA1B P35368 1/20 0.34
▸ LMNA P02545 3/20 0.34
▸ HTT P42858 3/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ NUDT1 P36639 1/20 0.33
▸ MAOB P27338 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26089894 0.86 MCL1 (0.40) MCL1BAK1GRM5ALDH1A1L3MBTL1
SCHEMBL26090272 0.81 CNR1 (0.39) MCL1BAK1GRM5ALDH1A1CNR1
SCHEMBL21967017 0.77 L3MBTL1 (0.46) MCL1BAK1GRM5ALDH1A1L3MBTL1
SCHEMBL29744714 0.77 L3MBTL1 (0.46) MCL1BAK1GRM5ALDH1A1L3MBTL1
SCHEMBL30407862 0.77 GRM5 (0.37) MCL1BAK1GRM5CNR1
SCHEMBL26438017 0.77 GRM5 (0.37) MCL1BAK1GRM5CNR1
SCHEMBL26088997 0.75 FEN1 (0.42) MCL1BAK1GRM5L3MBTL1CNR1
SCHEMBL19586153 0.74 L3MBTL1 (0.48) MCL1BAK1GRM5ALDH1A1L3MBTL1
SCHEMBL26087060 0.74 CNR1 (0.39) MCL1BAK1ALDH1A1L3MBTL1CNR1
SCHEMBL24206919 0.73 APP (0.45) GRM5L3MBTL1PKMCNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023069708-A1 COMPOUNDS THAT MEDIATE PROTEIN DEGRADATION AND USES THEREOF MONTE ROSA THERAPEUTICS, INC. (US) 2023-04-27 — — WO disclosed
Send feedback